HomeCancer

Cancer

Leukemia

Fastened-Period Acalabrutinib/Venetoclax Yields PFS Profit vs SOC in Frontline CLL

Editor -
Jennifer R. Brown, MD, PhDFastened-duration acalabrutinib (Calquence) plus venetoclax (Venclexta) with or with out obinutuzumab (Gazyva) within the frontline setting elicited a statistically...
Brain

Drug Born at Duke Improves Survival in Folks with Superior Mind Most cancers 

Editor -
Ines Batinic-Haberle, PhD, professor emeritus of radiation oncology at Duke College College of Medication, created lots of of compounds earlier than she stumble...
Research

WKU Nursing pupil receives Kentuckiana Most cancers Analysis Basis scholarship

Editor -
Kentuckiana Most cancers Analysis Basis introduced that WKU pupil Nicole Ossege of Fort Thomas is among the many first recipients of its annual...
Breast

Radio star Ali Clarke reveals she’s undergone mastectomy after shock breast most cancers prognosis

Editor -
Colorectal

FDA approves Guardant Well being’s blood take a look at for colon most cancers

Editor -
Shares of Guardant Well being (GH) rose after the US Meals and Drug Administration authorised the corporate's blood take a look at to...
1...272829...832Page 28 of 832

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.